360 related articles for article (PubMed ID: 33100263)
1. ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection.
Majumdar P; Niyogi S
Epidemiol Infect; 2020 Oct; 148():e262. PubMed ID: 33100263
[TBL] [Abstract][Full Text] [Related]
2. Molecular conservation and differential mutation on ORF3a gene in Indian SARS-CoV2 genomes.
Hassan SS; Choudhury PP; Basu P; Jana SS
Genomics; 2020 Sep; 112(5):3226-3237. PubMed ID: 32540495
[TBL] [Abstract][Full Text] [Related]
3. The ORF3a protein of SARS-CoV-2 induces apoptosis in cells.
Ren Y; Shu T; Wu D; Mu J; Wang C; Huang M; Han Y; Zhang XY; Zhou W; Qiu Y; Zhou X
Cell Mol Immunol; 2020 Aug; 17(8):881-883. PubMed ID: 32555321
[No Abstract] [Full Text] [Related]
4. Development of a Lateral Flow Strip Membrane Assay for Rapid and Sensitive Detection of the SARS-CoV-2.
Yu S; Nimse SB; Kim J; Song KS; Kim T
Anal Chem; 2020 Oct; 92(20):14139-14144. PubMed ID: 32967427
[TBL] [Abstract][Full Text] [Related]
5. A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a.
Firth AE
J Gen Virol; 2020 Oct; 101(10):1085-1089. PubMed ID: 32667280
[TBL] [Abstract][Full Text] [Related]
6. Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?
Eaaswarkhanth M; Al Madhoun A; Al-Mulla F
Int J Infect Dis; 2020 Jul; 96():459-460. PubMed ID: 32464271
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L
Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
[TBL] [Abstract][Full Text] [Related]
8. Host Immune Response Driving SARS-CoV-2 Evolution.
Wang R; Hozumi Y; Zheng YH; Yin C; Wei GW
Viruses; 2020 Sep; 12(10):. PubMed ID: 32992592
[TBL] [Abstract][Full Text] [Related]
9. SARS-Cov-2 ORF3a: Mutability and function.
Bianchi M; Borsetti A; Ciccozzi M; Pascarella S
Int J Biol Macromol; 2021 Feb; 170():820-826. PubMed ID: 33359807
[TBL] [Abstract][Full Text] [Related]
10. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.
Xu W; Wang M; Yu D; Zhang X
Front Immunol; 2020; 11():565278. PubMed ID: 33013929
[TBL] [Abstract][Full Text] [Related]
11. An association between exposure to Middle East Respiratory Syndrome (MERS) and mortality rate of Coronavirus Disease 2019 (COVID-19).
Naeem U; Naeem A; Naeem MA; Naeem K; Mujtaba B; Mujtaba A; Khurshid A
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9172-9181. PubMed ID: 32965011
[TBL] [Abstract][Full Text] [Related]
12. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
14. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
[TBL] [Abstract][Full Text] [Related]
15. Don't worry! The next generation would be more resistant to SARS-CoV-2.
Bevelacqua JJ; Mortazavi SMJ
Inflamm Res; 2020 Dec; 69(12):1159-1161. PubMed ID: 32989506
[No Abstract] [Full Text] [Related]
16. Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses.
Cagliani R; Forni D; Clerici M; Sironi M
Infect Genet Evol; 2020 Sep; 83():104353. PubMed ID: 32387562
[TBL] [Abstract][Full Text] [Related]
17. Will SARS-CoV-2 become endemic?
Shaman J; Galanti M
Science; 2020 Oct; 370(6516):527-529. PubMed ID: 33055131
[No Abstract] [Full Text] [Related]
18. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach.
Naqvi AAT; Fatima K; Mohammad T; Fatima U; Singh IK; Singh A; Atif SM; Hariprasad G; Hasan GM; Hassan MI
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165878. PubMed ID: 32544429
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
20. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
Assaad S; Avrillon V; Fournier ML; Mastroianni B; Russias B; Swalduz A; Cassier P; Eberst L; Steineur MP; Kazes M; Perol M; Michallet AS; Rey P; Erena-Penet AS; Morel A; Brahmi M; Dufresne A; Tredan O; Chvetzoff G; Fayette J; de la Fouchardiere C; Ray-Coquard I; Bachelot T; Saintigny P; Tabutin M; Dupré A; Nicolas-Virelizier E; Belhabri A; Roux PE; Fuhrmann C; Pilleul F; Basle A; Bouhamama A; Galvez C; Herr AL; Gautier J; Chabaud S; Zrounba P; Perol D; Blay JY
Eur J Cancer; 2020 Aug; 135():251-259. PubMed ID: 32540204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
